Lobbying Hits Record Highs Under Trump
Lobbyists in Trump’s fundraising circle are surging in a record-breaking year for influence spending, as companies like Pfizer cut deals with the White House.
Lobbyists in Trump’s fundraising circle are surging in a record-breaking year for influence spending, as companies like Pfizer cut deals with the White House.
Pfizer, Merck, Eli Lilly and other drug giants are spending record amounts on lobbying as they fight the Trump administration on vaccine policies and more.
The lobbying splurge coincides with Trump killing or weakening policies intended to lower drug prices that could impact company profits.
Here are the industries, companies, and trade associations that increased their spending on lobbying the most last year.
We run down the recipients of drugmaker donations revealed in PhRMA's latest tax filing.
Harris transition team adviser Covington & Burling works to influence the government for dozens of clients and is defending Amazon against the Federal Trade Commission.
House Democratic leadership groups have given more than a million dollars to the PhRMA-funded Center Forward, which has worked to undermine the Biden administration on drug pricing reforms and more.
The pharma lobby gave more than $16 million in 2022 to advocacy groups, many of them ostensibly “grassroots,” that are battling the Medicare drug price negotiations now underway.
The industry-funded group is celebrating 50 years with a gala in D.C.
Schrader’s new lobbying employer works for numerous drug companies like Pfizer and Sanofi, plus industry trade association PhRMA.